Traumatic spinal cord injury is frequently associated with brain injury and with alterations in respiratory and cardiovascular function that require critical care management. Complications include respiratory failure, atelectasis, pneumonia, neurogenic shock, autonomic dysreflexia, venous thromboembolism, and sepsis. While complications may be managed with supportive care, the goal of ameliorating neurologic outcome has proved elusive. Methylprednisolone, when instituted <8 hours after traumatic spinal cord injury, was associated in two clinical trials with statistically significant improvements in motor scores at 6 months and 1 year; however, critical reappraisal of these data raises questions about their validity and clinical relevance. Until more evidence of clinically effective therapies is available, acute management must be driven by pathophysiologic principles, with emphasis on interventions that attenuate secondary neurologic injury; these include the rational use of immobilization, cautious airway management, and promotion of cord perfusion and oxygenation with the appropriate level of hemodynamic and respiratory support. Clinical trials of pharmacologic neuroprotection have yielded disappointing results, but the ongoing elucidation of spinal cord repair and regenerative mechanisms suggests new therapeutic prospects.
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This review is centered on conditions that are encountered in a critical care or perioperative setting, in particular, traumatic SCI. The acute ischemic myelopathy that may be observed as a complication of surgery of the descending aorta is reviewed elsewhere. 2, 3 In the United States, traumatic SCI with or without bony injury has an annual incidence of 28 to 55 per million, with an ave rage of 10,000 new cases a year and a prevalence of 200,000. 4 The actual incidence may be even greater because reported statistics do not include individuals who die before admission to the hospital and who account for 16% to 30% of cases. 5 The average age at the time of injury is 32 years and the male/female ratio is 4:1. More than half (55%) of traumatic SCI involves the cervical cord. The most common causes of SCI are traffic accidents (motor vehicle, bicycle, pedestrian) (40%-50%), assault (10%-25%), falls (20%), work-related injuries (10%-25%), and sports/recreation-related injuries (10%-25%). 3, 5 In the United States, the total annual costs of treating patients with SCI is estimated at four to nine billion dollars. 4 In traumatic cervical SCI, 3-month mortality is 20% to 21%, and independent predictors of mortality are level of cord injury, Glasgow Coma Scale, age, and respiratory failure. 6, 7 The most consistent predictor of long-term outcome is the severity of neurologic injury, which may be characterized by the level and completeness of sensorimotor loss. [8] [9] [10] [11] Principal causes of death are respiratory disorders, cardiovascular disorders, pulmonary embolism, infections, and suicide. 11, 12 Survival of patients with traumatic SCI has improved over the past decades. 13, 14 In a cohort of patients with SCI followed over 40 years, life expectancy of complete tetraplegics was 70% of that expected in comparable noninjured subjects, whereas the life expectancy was 84% in complete paraplegics and 92% in patients with incomplete SCI. 12 Better prognosis is thought to reflect changes in prehospital care, rapid triage to facilities with SCI expertise, and advances in medical, surgical, and rehabilitative care; however, specific factors linked to improved outcome have not been clearly identified.
ANATOMY
The adult spinal cord 15 extends from the medulla oblongata to the L1-L2 vertebral level. It is encased in the spine whose individual segments are linked by facet joints and intervertebral discs and bound by an extensive ligamentous apparatus. The cervical spine and thoracolumbar junction have the greatest mobility and are most vulnerable to injury, whereas the incidence of fractures is much lower at the thoracic level. The spinal cord is enveloped in three layers of meninges; however, unlike the brain, the dura at the cord level is delimited by a densely vascular and relatively compliant epidural space into which pathologic processes such as abscesses, hematoma, and metastases may spread by a path of least resistance. Transverse sections of the cord reveal a characteristic H-shaped mass of gray matter enfolded in a mantle of white matter made of ascending and descending tracts. Of the many white matter tracts, only three can be readily assessed by physical examination: 1) the posterior columns conveying fine touch, vibration, and position sense, 2) the posterolateral corticospinal tract transmitting motor commands, and 3) the anterolateral spinothalamic tract containing fibers for pain, temperature, light touch, and pressure sensation. White matter columns are organized somatotopically, with medial cervical fibers and lumbosacral elements placed laterally. Spinal cord blood supply is provided by one anterior and two posterior spinal arteries, which are branches of the vertebral arteries and are augmented by radicular branches of the thyrocervical, costocervical, intercostal, and lumbar vessels. The anterior spinal artery supplies the ventral two thirds of the cord, the remaining dorsal region being supplied by the posterior arteries. Tissues at the boundary between anterior and posterior spinal arteries and between thoracic segmental arteries are at risk for "watershed" type infarction. Venous blood from the cord is drained by internal and external vertebral plexuses that ultimately run into the intracranial venous sinuses or into the caval system. Spinal cord blood flow (SCBF) has many of the characteristics of cerebral blood flow, averaging 40 to 60 mL · 100 g −1 · min −1 , autoregulating between mean arterial pressures of 60 and 150 mm Hg and increasing with hypercapnia and severe hypoxemia. 16 As in traumatic brain injury, SCI is associated with loss of autoregulation.
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PATHOPHYSIOLOGY
Traumatic SCI is commonly viewed as a sequence of primary and secondary pathogenetic events. 18 Primary injury is the damage incurred during the initial insult; it is typically maximal at onset and unlikely to be modified by therapeutic intervention. Secondary injury unfolds during the hours to days following the insult; it refers to a cascade of tissue injury, including 1) vascular compromise with impaired vasomotor function, ischemia, hemorrhage, vasospasm, thrombosis, and increased permeability, 19 2) inflammatory changes with release of chemokines, cytokines, and eicosanoids and expression of cell adhesion molecules and leukocyte infiltration, and 3) cellular dysfunction with adenosine triphosphate depletion, plasma membrane failure, free radical generation, lipid peroxidation, excitatory amino acid release, cellular calcium overload, and mitochondrial insufficiency. A hallmark of secondary injury is spinal cord edema, which may present clinically as neurologic deterioration and on magnetic resonance imaging (MRI) as parenchymal signal abnormalities; cord edema typically peaks 3 to 6 days after injury and subsides over a period of weeks. Beyond these acute changes, SCI may continue to unfold weeks and months after injury, namely, through apoptotic cell death, glial scar formation, and the generation of cystic cavities. 20, 21 The clinical significance of secondary cord injury is that it is exacerbated by systemic variables such as hypotension, shock, decreased arterial oxygen content, catecholamine release, hypercoagulability, and hyperthermia. Aggressive prevention and/or correction of such ab-normalities are accordingly cardinal goals for the intensivist and anesthesiologist.
DIAGNOSIS
Clinical Assessment
Clinical assessment of SCI begins with an evaluation of airway, breathing, and circulatory function. Physical examination should be attentive to noncord injuries, which are present in 20% to 60% of patients with SCI, most significantly involving the head, chest, or abdomen. 4 Traumatic brain injury occurs in 25% to 50% of patients with SCI; conversely, 5% to 10% of head-injured patients have an associated SCI. 22, 23 The physical examination performed in the first days after traumatic SCI is highly predictive of short-and longterm outcome. 6, 7, [8] [9] [10] The spine should be inspected for deformity and palpated to elicit tenderness or a "step-off," indicating a widened interspinous space. Motor and sensory function and deep tendon reflexes should be documented. Careful note should be made of changes in cognitive function, level of consciousness, and cranial nerve abnormalities that might signal concomitant brain or brainstem injury. Early neurologic findings may be confounded by spinal shock, characterized by flaccid areflexic paralysis and anesthesia to all modalities. Spinal shock is present in one half of patients with SCI, and its pathogenesis is poorly understood; it has a variable time course but in most cases resolves in <24 hours. Although the terms are sometimes used interchangeably, it is preferable to distinguish spinal shock from neurogenic shock. Spinal shock refers to an acute, transient neurologic syndrome of sensorimotor dysfunction that develops with SCI at any level, whereas neurogenic shock is a hemodynamic syndrome associated with upper thoracic and cervical SCI and is characterized by bradycardia and decreased systemic vascular resistance. The two patterns may or may not occur concurrently.
The neurologic level is defined as the most caudal segment of the spinal cord with normal bilateral motor (strength >3/5) and sensory (light touch and pinprick) function. An injury is said to be complete when all sensory and motor function below the lesion is abolished; in complete injury, abnormal motor or sensory findings subjacent to the neurologic level are referred to as the zone of partial preservation. Any residual voluntary motor function or sensation that is not contiguous with the neurologic level qualifies as incomplete injury. Standardized neurologic assessment tools have been developed for SCI, the most widely used of which is the American Spinal Injury Association (ASIA) classification, composed of a motor score that grades strength in 10 muscle groups in the upper (C5-T1) and lower (L2-S1) extremities, and a sensory score based on the light touch and pinprick responses in 28 dermatomes. 24 A related tool, the ASIA impairment scale, combines severity of deficits with completeness of injury, stratifying patients into five classes that correlate with outcome ( Table 1) . 24 Depending on anatomic localization, a number of clinically distinct spinal cord syndromes have been described and are outlined in Table 2 .
Imaging
The primary goal of imaging is to rapidly and accurately identify injury of the spine that places neural tissue at risk. Imaging should be obtained in all trauma patients with risk factors for spine or cord injury; these include patients with 1) neck or back pain or tenderness, 2) sensory or motor deficits, 3) impaired level of consciousness, 4) alcohol or drug intoxication, and 5) painful injuries that may distract the patient from spine injury. Greater than 95% of patients with cord injury have concomitant spine injury (fracture and/or dislocation). 25 Patients with cordinduced deficits who do not have any spine abnormality or injury detectable with plain radiographs or computed tomography (CT) are referred to as SCI without radiographic abnormality (SCIWORA). Originally described in children, SCIWORA constitutes up to 15% of adults with SCI; however, the incidence may be lower if magnetic resonance imaging (MRI) is used to diagnose occult intervertebral disc or ligamentous injury. 26, 27 
Radiographs
Standard cervical spine radiographs include the anteroposterior, lateral, and odontoid views. Lateral films should be assessed in a systematic fashion for 1) technical adequacy with particular attention to whether or not the entire cervical spine and the C7-T1 intervertebral space are visualized and 2) for abnormalities in vertebral alignment, bony structure, intervertebral space, and soft tissue thickening.
Computed Tomography
CT is indicated if the spine is not adequately visualized or appears abnormal on plain radiographs, or if there is a high clinical suspicion of injury despite technically adequate films that show no injury. In a recent prospective study, 67 of 70 patients with C1-3 injuries were correctly identified by CT with 2 mm cuts, versus 38 of 70 correctly identified by plain films. 28 Helical CT allows sagittal and three-dimensional reconstruction and may provide a greater degree of accuracy. 29 However, these studies have been construed as flawed because they lack a gold standard of clinically relevant spine injury against which the imaging techniques may be measured. 30 Although the role of CT as a single diagnostic modality is uncertain, the negative predictive value of combined of threedimensional view plain films and CT is >99%. 28, 31, 32 Magnetic Resonance Imaging MRI is the modality of choice for characterizing acute cord injury, but it may be less sensitive than CT or plain films in distinguishing bony abnormalities, in particular, those of the posterior portion of the spine. 33 MRI detects spinal cord edema and hemorrhage, ligamentous injury, and other nonosseous changes that can be missed with other techniques; however, the interpretation of many ligamentous lesions identified with MRI is unclear, and concern exists that MRI may "overcall" significant injury. 30 
Clearing the Cervical Spine
Initial management of trauma patients assumes that the cervical spine is unstable until proven otherwise. Rapidly establishing stability, or "clearing," of the cervical spine is a management priority and should be undertaken in a systematic fashion. All patients with trauma should be screened for clinical risk factors of cord or spine injury. Prospective studies have shown that when all five clinical risk factors (neck pain or tenderness, neurologic deficits, impaired level of consciousness, intoxication, or painful distracting injuries) are absent, cervical spine injury may be ruled out with a high degree of confidence (negative predictive value >99%), [34] [35] [36] and recent neurosurgical guidelines emphasize that radiographic assessment be withheld in patients that meet these exclusionary criteria. 37 Patients with clinical risk factors should be imaged with three-view radiographs supplemented by CT if plain radiographs are abnormal or inadequate. Those with neck pain or tenderness and normal three-view series may be assessed with dynamic flexion-extension radiographs or MRI. Negative flexion-extension films or negative MRI within the first 48 hours of injury, together with normal plain radiographs and CT, are thought to be sufficient to clear the cervical spine. In comatose or intoxicated patients with normal plain films and CT, the incidence of spine injury is <1%; if suspected clinically, flexionextension views obtained under fluoroscopic guidance or MRI if performed <48 hours after injury may be useful. [38] [39] [40] MRI is highly sensitive but lacks specificity, and falsely positive studies may lead to undue prolongation of immobilization and its inherent risks.
CRITICAL CARE MANAGEMENT
Management of SCI is directed toward limiting secondary injury and maximizing neurologic recovery. This may be achieved surgically by relieving or preventing compression of neural structures and medically by optimizing cord perfusion and oxygenation and by disrupting cell injury mechanisms.
Concept of Spinal Stability
Stability is the capacity of the spine to withstand physiologic loading and positioning without neurologic injury, deformity, or pain. 41 Stability is predicted using clinical and anatomic characteristics and is critical in decisions regarding airway and surgical management. For the thoracolumbar spine, a three-column concept based on CT imaging is widely used; damage to two or more columns results in instability. 42 For the cervical spine, stability is scored according to a system that integrates static and dynamic clinical and radiographic criteria. 43 
Immobilization
The goal of immobilization is to prevent or limit secondary neurologic injury in the presence of an unstable spine. Because spinal injury can occur at several noncontiguous levels, immobilization of the entire spine is recommended until injury is ruled out with appropriate physical examination and imaging. Common measures include immobilization of the head between two sandbags, placement of a rigid cervical collar, transportation on a rigid spine board, and log rolling of the patient. The rationale for immobilization seems unambiguous, and it is widely viewed as a standard of care in patients at risk for spine injury. Nonetheless, immobilization is not a benign intervention as it may be complicated by pain, pressure sores, and impaired chest wall mobility in up to 70% of patients; in addition, neck immobilization is thought to increase the risk of airway compromise, difficult intubation, aspiration, and increased intracranial pressure. 44, 45 
Surgery
Goals of surgical management in patients with traumatic spine and SCI are 1) to decompress neural tissue and 2) to prevent cord injury by ensuring mechanical stability of the spine. Options include bed rest in traction, external immobilization, and open reduction with internal fixation. Many clinicians have abandoned traction because of the complications associated with prolonged bed rest.
Numerous aspects of surgical management of SCI are debated. 46 Two recent systematic reviews concluded that 1) data are insufficient to generate specific treatment standards or guidelines for surgical management, 2) in patients with cord compression and stable neurologic findings, early (ie, <24 hours after injury) surgical intervention has not been shown to improve or worsen neurologic outcomes, when compared with delayed decompression, and 3) although compelling data are lacking, urgent decompression is indicated in patients with irreducible bilateral facet dislocation and incomplete tetraplegia, and in the presence of a rapidly deteriorating neurologic deficits.
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Airway
Indications for endotracheal intubation in patients with SCI are listed in Table 3 . Intubation in the setting of an unstable spine has been linked to severe cord injury and death. 49, 50 Conversely, the imperative of maintaining spine immobilization can augment the difficulty of airway management. In trauma patients, intubating conditions may be aggravated by concomitant injuries of the face and neck and obstruction of the airway by blood, vomitus, foreign bodies, edema, or retropharyngeal hematoma. Studies in individuals without spine injury, in intact cadavers, and in cadavers with cervical spine injury indicate that varying degrees of displacement of cervical spine elements occur with nearly all airway interventions, including chin lift, jaw thrust, cricoid pressure, mask ventilation, laryngeal mask airway placement, combi-tube placement, laryngoscopy, and orotracheal tube placement. [51] [52] [53] [54] However, it is unclear to what degree these data may be extrapolated to patients with spine injury. Postulated mechanisms of peri-intubation cord injury include mechanical compression, vascular compromise, and obstruction of cerebrospinal fluid; moreover, intubation is frequently followed by events that may independently precipitate or potentiate SCI, including surgical manipulation, changes in position, hypotension, and hypoxia. McLeod and Calder propose five clinical criteria that would suggest a causal link between laryngoscopy and neurologic injury: 1) presence of myelopathy on recovery from sedating agents or anesthesia, 2) a short interval between laryngoscopy and return to consciousness, 3) autonomic instability following laryngoscopy, 4) difficult laryngoscopy, and 5) disease of the craniocervical junction or instability below C3. Although intuitively satisfying, the validity of these criteria is unknown. 50 Airway management strategies that address the problem of spine instability include blind nasotracheal intubation, direct laryngoscopy with manual in line stabilization, and awake fiberoptic intubation. Manual in line stabilization requires a second operator to hold the head in a neutral position while the trachea is cannulated; it has been shown to limit, but not abolish, cervical spine movement and is thought to be safer than axial traction. 51 Fiberoptic intubation is an attractive option because immobilizing devices are not removed and displacement of the spine is reduced to a minimum; however, unwanted neck movement may occur during topical local anesthetic application or if topicalization of the airway is insufficient. Whether specific airway techniques impact differentially on neurologic risk is unknown. Guidelines for airway management are given in Table 4 .
Respiratory Management
Abnormal respiratory function and pulmonary complications are a prominent concern in patients with cervical SCI. Respiratory failure is an independent predictor of 3-month mortality, 6, 7 and pulmonary complications are the leading causes of death and morbidity in patients with SCI.
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Pathophysiologic Alterations
Neurogenic respiratory failure can result from lesions in the pons, medulla, cord, peripheral nerves, and neuromuscular junction. Breathing at rest is active in inspiration and passive in expiration. The diaphragm (C3-C5) and intercostals (T1-T11) are the principal inspiratory muscles, while the sternocleidomastoid, trapezius (both cranial nerve XI), and scalene (C3-C8) are accessory inspiratory muscles. Active expiration is characteristic of respiratory distress and is provided by the muscles of the anterior abdominal wall: rectus (T8-L2), obliques (T7-L2), and transversus (T7-L2). Effective coughing and clearance of secretions are also dependent on expiratory muscle function.
Cervical cord injury is associated with significant alterations in ventilatory control, breathing patterns, respiratory mechanics, and bronchial reactivity. 55 Respiratory muscle weakness leads to alveolar hypoventilation and hypercapnic hypoxemic respiratory insufficiency. Recruitment of accessory muscles with inspiration results in expansion of the upper rib cage while the flaccid diaphragm ascends into the thoracic cavity, generating a paradoxical inward movement of the lower rib cage and abdominal wall. All lung volumes except the residual volume are significantly reduced, producing a clinical pattern of rapid shallow breathing and a restrictive defect on pulmonary function testing. 56 Pulmonary and chest wall compliance is decreased, contributing to a greater work of breathing. 57 Severity of ventilatory dysfunction after SCI correlates with the level and the completeness of the lesion. In a prospective observational study, the mean duration of mechanical ventilation was 65 days for patients with C1-C4 lesions, 22 days in patients with C5-C8 injury, and 12 days for patients with thoracic injury. Complete injury above the C3 level entails apneic respiratory arrest and death unless immediate ventilatory assistance is provided. Survivors have the highest mortality when compared with other SCI injury levels, are at significant risk for pulmonary complications, and need long-term ventilatory support or diaphragmatic pacing.
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Injury at C3-C5 is associated with variable degrees of respiratory failure. Acutely these patients have markedly reduced lung volumes requiring ventilatory support, but a significant proportion are liberated from mechanical ventilation weeks to months after injury. 59 Ventilatory function has a characteristic time course, worsening during the first 2 to 5 days after injury and then progressively improving, although never returning to baseline. Recovery of function reflects functional descent of the neurologic injury level with attenuation of cord edema, recruitment of accessory respiratory muscles, and retraining of deconditioned muscles. Progressive spasticity of chest wall muscles may assist with weaning by increasing thoracic stability with better transduction of residual muscle force into lung volume. 60 Injury below C5 is associated with lesser degrees of ventilatory impairment, but patients remain at risk for pulmonary complications. Effective coughing and the ability to clear secretions are limited by paralysis of expiratory muscles, increasing risk of atelectasis, and pneumonia. In this group and in thoracic spine or cord injury, respiratory failure commonly is the result of direct chest trauma (pneumothorax, hemothorax, flail chest, and pulmonary contusions).
Atelectasis, pneumonia, aspiration pneumonitis, pulmonary edema, pleural effusions, and pulmonary embolism occur in more than two thirds of patients with cervical and upper thoracic SCI. Pulmonary complications are promoted by, and may exacerbate, underlying neurogenic ventilatory insufficiency, generating a spiral of deteriorating respiratory function. Pulmonary edema may reflect myocardial injury, excessive fluid administration, neurogenic pulmonary edema, or acute respiratory distress syndrome.
Management
Mechanical ventilation is beneficial in selected patients with SCI by reversing hypoxemia and hypercapnia, decreasing the work of breathing, reexpanding collapsed lung units, and facilitating pulmonary toilet. Rapid correction of hypoxemia and respiratory acidosis may be critical in limiting the extent of secondary cord injury. 18 Although of unknown benefit in this patient population, potentially useful interventions include noninvasive ventilation, aggressive pulmonary hygiene (suctioning, chest percussion, positional changes, deep breathing, incentive spirometry), and bronchodilator therapy. 55 There are few data correlating a specific ventilator management strategy with respiratory outcomes and successful weaning in SCI. Patients with complete cord injuries at the C3 level or above require full ventilator support modes such as controlled mandatory ventilation or assist-control. With incomplete injury and injury below C3, modes that incorporate spontaneous breathing (eg, pressure support ventilation, synchronized intermittent mandatory ventilation) may limit respiratory muscle deconditioning and atrophy and promote weaning. Many clinicians advocate larger tidal volumes (10-15 mL per kg), intermittent sighs, or positive end-expiratory pressure to enhance recruitment of atelectatic lung units. However, the use of larger tidal volumes may be injurious, particularly in the setting of acute respiratory distress syndrome. 61 Early tracheostomy should be considered when the need for ventilatory support is anticipated to exceed 2 to 3 weeks. Tracheostomy has been associated with enhanced subjective tolerance, decreased dead space ventilation, reduced airway resistance, and perhaps shorter ventilator weaning when compared with orotracheal intubation.
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Cardiovascular Management Neurogenic Shock
Cardiovascular instability is a frequent complication of SCI, especially when the upper thoracic or cervical cord is involved. Sympathetic denervation results in arteriolar dilation and pooling of blood in the venous compartment, while interruption of cardiac sympathetic innervation (T1-T4) promotes bradycardia and reduces myocardial contractility. Neurogenic shock is suggested by a pattern of decreased heart rate, blood pressure, and systemic vascular resistance. Impaired systolic function may become apparent as congestive heart failure, particularly if fluids are administered injudiciously. Experimental data indicate that hypotension and shock are particularly deleterious to the injured spinal cord, contributing to cord hypoperfusion and perpetuating secondary injury. 18 Animal models also show that cardiovascular depression may be preceded by a transient phase of severe hypertension thought to reflect a massive, simultaneous discharge of sympathetic neurons. This hyperadrenergic response may be a factor in the subendocardial myocardial injury and neurogenic pulmonary edema, which have been observed after SCI and other forms of CNS injury. 63 
Hemodynamic Support
Hemodynamic management in SCI is inferred from the data on traumatic brain injury, which states that blood pressure should be targeted to cerebral perfusion pressure goals. In SCI, however, there is no clinically useful method of assessing spinal cord perfusion pressure, and a relationship between hemodynamic management and neurologic outcome has yet to be demonstrated in clinical trials. Five retrospective series [64] [65] [66] [67] [68] and one prospective uncontrolled study 69 suggest that hemodynamic support with volume expansion and/or blood pressure augmentation can be conducted safely and may be associated with better neurologic results after SCI. However, it is unclear how these results are to be interpreted given the lack of appropriate comparative groups and the presence of confounding variables, including monitoring and management in an ICU. A reasonable strategy is one in which 1) hypotension is rigorously avoided and 2) cord perfusion is optimized with volume expansion and blood pressure augmentation, so long as these interventions do not impact unfavorably on other organ systems. 70 The clinician managing traumatic SCI should be attentive to all potential causes of hemodynamic instability, including neurogenic shock, bleeding, tension pneumothorax, myocardial injury, pericardial tamponade, and sepsis. When the primary hemodynamic disturbance is deemed to be neurogenic, a stepwise approach is useful, beginning with volume resuscitation and progressing to pharmacologic support, ideally guided by invasive hemodynamic monitoring. To avoid congestive heart failure, fluids should be titrated with particular attention to incremental changes in cardiac output and filling pressures. In the presence of decreased systemic vascular resistance and adequate cardiac output and heart rate, a vasopressor such as phenylephrine or norepinephrine may be used. If cardiac output and/or heart rate are decreased, an agent with inotropic properties such as dopamine is likely to be more useful.
Venous Thromboembolism
Individuals with acute SCI have the highest risk of venous thromboembolic disease among all hospital admissions. 71, 72 The incidence of deep venous thrombosis (DVT) in patients with SCI not receiving prophylaxis is 39% to 100%, compared with 9% to 32% in untreated medical and surgical ICU patients. 72 In a large prospective evaluation of trauma patients, SCI was the strongest independent predictor of DVT, with an odds ratio of 8.59. 73 A recent meta-analysis indicated that patients with SCI have a more than threefold risk of sustaining a DVT compared with trauma patients without cord injury. 74 Among patients with SCI, DVT risk is higher with complete versus incomplete lesions, with thoracic versus cervical level injury, and during the first 3 months after injury. 72 The incidence of pulmonary embolism after SCI and in the absence of prophylaxis is less well documented but is estimated at 4% to 10%. 72, 75 Pulmonary embolism is one of the three most common causes of death after SCI. 11, 12 There is as yet no well-powered, adequately controlled randomized trial of DVT prophylaxis in SCI. Small-scale investigations have focused on a variety of regimens including low-dose unfractionated heparin, adjusted dose unfractionated heparin, low molecular weight heparin, warfarin, aspirin/dipyridamole, pneumatic compression devices, graduated compression stockings, electrical stimulation, rotating beds, and vena cava filters. These studies are heterogeneous in design, type of prophylaxis, timing of intervention, and tests used to diagnose DVT. Recently, much of these data were analyzed in two systematic reviews 71, 74 and in two evidence-based consensus conferences 72, 76 Table 6 which recommend that patients with SCI receive prophylaxis with either low molecular weight heparin or low-dose unfractionated heparin combined with a nonpharmacologic device (pneumatic compression, elastic stockings). Although there is agreement that prophylaxis is necessary, uncertainty persists as to which is the best prophylactic regimen, whether low molecular weight heparin combined with nonpharmacologic means is superior to either alone, how soon after SCI it may be instituted, how long it should be continued, and the utility of vena cava filters in this high-risk population.
Pharmacologic Cord Protection
Elucidation of the cellular and molecular underpinnings of SCI has spurred investigation of a number of pharmacologic strategies targeted at secondary injury mechanisms. Agents that have been tested in human clinical trials include corticosteroids, tirilazad mesylate, naloxone, and GM-1 ganglioside. 77 Animal models indicate that corticosteroids attenuate inflammatory changes, edema, lipid peroxidation, excitotoxicity, and cytoskeletal degradation associated with SCI. Based on results of several randomized controlled trials 78, 79, 117 and follow-up studies, 80,81,118 methylprednisolone therapy has been introduced into widespread clinical practice and is regarded as a standard of care in the management of traumatic acute SCI. However, close critical scrutiny has revealed flaws in the design, reporting, and interpretation of these trials, [82] [83] [84] and a more recent randomized trial indicated no difference in neurologic out-come between methylprednisolone-and placebo-treated patients 85 (Table 5 ). In a consensus conference, the American Association of Neurologic Surgeons and the Congress of Neurologic Surgeons stated: "Treatment with methylprednisolone for either 24 or 48 hours is recommended as an option in the treatment of patients with acute spinal cord injuries that should be undertaken only with the knowledge that the evidence suggesting harmful side effects is more consistent than any suggestion of clinical benefit." 84 GM-1 ganglioside, a glycolipid found in abundance in the outer leaflet of neuronal and glial plasma membranes, has both neuroprotective and neuroregenerative properties 77 . Its role in the treatment of acute SCI has been investigated in two randomized controlled trials. 86, 87 In the first of these, significantly better motor scores and Frankel scales were observed at 1 year in patients receiving GM-1 ganglioside compared with placebo. 86 In a follow-up multicentric trial, neurologic function as measured by functional and motor scores at 26 weeks was not significantly different between groups GM-1 ganglioside and placebo groups. 87 Interestingly, patients in the control group, all of whom received methylprednisolone in doses equivalent to NASCIS II, did not reproduce the modest neurologic gain over time that was seen in the prior study.
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Other Critical Care Issues (Table 7) Infectious complications are a leading cause of death and morbidity after SCI, most frequently involving the lungs and urinary tract. 11, 12 Among trauma patients, the presence of SCI is a strong independent predictor of infection. 88 There is evidence that individuals with SCI have dysfunctional immune responses, possibly in proportion to the severity of the neurologic deficit. 89 Factors that may increase the risk of pneumonia are aspiration, prolonged tracheal cannulation, reduced ability to clear secretions, and atelectasis. Urinary tract infections are promoted by incontinence, elevated intravesical pressure, reflux, stones, and neurologic obstruction. High doses of corticosteroids are associated with an increased rate of infectious complications. 78, 79, 85 When an infectious source is not apparent, consideration should be given to acute abdominal processes that may be clinically occult in SCI, namely, pancreatitis, cholecystitis, diverticulitis, bowel perforation, or bowel ischemia.
Acute SCI increases the risk of stress ulceration and upper gastrointestinal bleeding, in particular, when associated with mechanical ventilation and high-dose corticosteroids. There is no specific data on stress ulcer prophylaxis in SCI; however, it is suggested that all patients with acute SCI receive an H2 antagonist or sucralfate, as the efficacy of these agents has been demonstrated in other critically ill patient populations. 105 Acute SCI may also be associated with gastric distension and ileus, contributing to the risk of aspiration and further compromising respiratory function; nasogastric or orogastric suctioning and the use of prokinetic agents such as metoclopramide or erythromycin may be useful in this setting.
Psychiatric complications are common after SCI and include depression (30%-40% of individuals), anxiety disorders (20%-25%), and substance-related disorders (40%-50%). [91] [92] [93] Risk of suicide is increased two to six times when compared with the general population. 93 In the intensive care unit, every effort should be made to promote appropriate relief from pain and anxiety. The potential role of other interventions such as psychiatric counseling in the acute setting has not been studied.
PERIOPERATIVE MANAGEMENT
Anesthesia for acute SCI recapitulates many of the concerns relevant to the critical care setting (Table 7) . Preop- erative assessment should be attentive to associated injuries, airway characteristics, oxygenation, ventilatory capacity, hemodynamic variables, and neurologic examination. An anesthetic plan should be devised with particular attention to the technique for securing the airway, anticipated need for hemodynamic support, likelihood of extubation, and indication for postprocedure ICU admission. Patients with acute SCI undergoing surgery will almost universally require general anesthesia. In selected patients with chronic SCI undergoing surgery below the level of the lesion, some authors have advocated alternative strategies including monitored anesthesia care, spinal, or epidural anesthesia. 94, 95 In this patient group, benefits of regional anesthesia need to be carefully weighed against risks, which include difficulty in assessing the level of anesthetic block, hypotension, and the potential for neurotoxicity in the setting of injured neural tissue.
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Positioning
Positioning of the patient to achieve adequate exposure and reduction of the spine must be accomplished with close attention to complications, which include worsening of neurologic injury; abdominal compression with venous engorgement and increased intraoperative bleeding; impaired chest wall compliance; ischemic optic neuropathy; and peripheral nerve injury. In patients with SCI with impaired sympathetic outflow to the vasculature or heart, changes in position may have significant hemodynamic consequences; sudden adoption of the head-up position may lead to severe hypotension through venous pooling of blood, whereas the head-down position may precipitate cardiac failure.
Electrophysiologic Monitoring
During spine surgery, distraction, instrumentation, or direct compression of cord vascular structures may significantly affect SCBF and promote cord infarction if uncorrected. 97, 98 Spine surgery conducted in the prone position increases intraabdominal and vertebral venous pressure, possibly promoting venous cord infarction. 99 Somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs) may assist in the detection of intraoperative spinal cord dysfunction, prompting corrective interventions before irreversible neural damage has occurred. While numerous reports attest to the helpfulness of these techniques, their impact on postoperative outcomes has not been tested in a prospective randomized fashion. 100, 101 SSEPs assess the ascending sensory tracts located in the posterior columns, whereas MEPs evaluate the descending anterior and posterolateral corticospinal tracts. 100, 101 During surgery of the spine, SSEP identifies new-onset cord dysfunction with a sensitivity of >95%, but the specificity of the monitor is disappointing, with a high false-positive rate reflecting multiple confounding variables including anesthetic agents, hypothermia, or hypotension. 102 Limited evidence indicates that MEPs may be as sensitive as SSEPs during spine surgery; however, the clinical validity of MEPs, alone or in combination with SSEPs, needs further clarification.
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Hemodynamic Management
Hypotension is associated with neurologic deterioration in patients with SCI and must be circumvented by judicious administration of anesthetic agents, fluid resuscitation, and vasopressor and/or inotropic support when needed. Placement of a central venous catheter and an arterial line may assist with intravascular volume and blood pressure management. Pulmonary artery catheterization or transesophageal echocardiography should be considered in the presence of severe hemodynamic compromise. Using pulmonary artery catheters, Mackenzie et al. demonstrated diminished cardiac output responses to fluid loading in a subset of acutely tetraplegic patients undergoing surgery, indicating impaired left ventricular function.
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Autonomic Dysreflexia
Autonomic dysreflexia is a cluster of symptoms characterized by paroxysmal hypertension, headache, and bradycardia in response to a stimulus originating below the level of the SCI. 104 It appears in up to 90% of patients with lesions above T6, and its severity is greater the higher the level of SCI. Onset of symptoms may occur weeks to years after the initial injury. Common precipitating events include distension of hollow viscera (bladder, bowel, uterus, gallbladder), cutaneous stimulation, and surgical procedures, frequently involving pelvic organs or the lower extremities. 94, 104 Below the level of the lesion, clinical signs include cutaneous vasoconstriction, piloerection, and bladder spasm, while above the lesion level patients present with cutaneous flushing, sweating, nasal and conjunctival congestion, blurred vision, and nausea. Untreated, autonomic dysreflexia can lead to encephalopathy, stroke, seizures, intracerebral or retinal hemorrhage, myocardial infarction, congestive heart failure, arrhythmias, and death. Suggested pathophysiological mechanisms include loss of supraspinal inhibitory control of segmental sympathetic neurons, adrenergic receptor upregulation, and abnormal synaptic connections due to postinjury sprouting. 105 Management priority is removal of the precipitating stimulus. If the crisis occurs intraoperatively, deepening the level of anesthesia may be helpful. Hypertension should be controlled with vasodilating agents such as nitroprusside, hydralazine, phentolamine, or nicardipine.
Anesthetic Agents
Anesthetic agents exert profound effects both on neuronal function and blood flow in the spinal cord. Minimum alveolar concentration of volatile anesthetics is unaffected by decerebration or cervical cord transsection, suggesting that unresponsiveness to noxious stimuli during general anesthesia is mediated by anesthetic effects at the cord level.
106,107 SCBF and cerebral blood flow are similarly influenced by anesthetic agents, increasing with potent inhalational agents, decreasing with thiopental. SCBF increases observed with isoflurane are concomitant with decreases in spinal cord neuronal activity, indicating flow-metabolism uncoupling as is observed in the brain. 108 The clinical significance of these results is unknown, although a neuroprotective effect on the spinal cord has been suggested for thiopental. 109 There are no data to support the use of one anesthetic agent over another in patients with SCI. Succinylcholine is contraindicated because of the potential for lethal hyperkalemic responses related to potassium efflux from extrajunctional acetylcholine receptors. 110 The risk of this complication is apparent within 24 hours after SCI and may be relevant for up to 18 months.
REGENERATION
Treatment of acute SCI is currently centered on mitigating secondary injury by the institution of a limited number of physiologic interventions whose ability to modify neurologic outcomes is unproven. As with stroke and traumatic brain injury, clinical trials of neuroprotective agents have consistently failed to demonstrate a favorable effect on neurologic function after SCI.
In recent years a growing body of work has challenged the classic paradigm that neuronal repair and cellular renewal cannot occur in the central nervous system. In the injured spinal cord, for instance, axonal regrowth may be coaxed by selectively targeting inhibitory signals expressed on myelin sheaths and in the glial scar. 111 Interventions for SCI that are being investigated in animal models include 1) promoting axonal regrowth with neurotrophic factors (BDNF, GDNF, NT3, nerve growth factor) 112 ; 2) blocking myelin-associated inhibition (antiNogo antibody, anti-MAG antibody, Nogo peptide) 113 ; 3) removing the inhibitory extracellular matrix components of scar tissue (chondroitinase ABC) 114 ; 4) bridging spinal cord lesions with cellular scaffolds that support axonal growth (olfactory-ensheathing cells, Schwann cells) 115 ; and 5) transplantation of precursor cells to reconstitute lost tissue. 116 Therapeutic implementation of such strategies in humans may fulfill the goal of restoring function in this predominantly young patient population.
